Form 8-K - Current report:
SEC Accession No. 0001104659-25-007198
Filing Date
2025-01-29
Accepted
2025-01-29 16:03:20
Documents
20
Period of Report
2025-01-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254675d1_8k.htm   iXBRL 8-K 51464
5 GRAPHIC tm254675d1_8kimg001.jpg GRAPHIC 77338
6 GRAPHIC tm254675d1_8kimg002.jpg GRAPHIC 17697
7 GRAPHIC tm254675d1_8kimg003.jpg GRAPHIC 57326
8 GRAPHIC tm254675d1_8kimg004.jpg GRAPHIC 37060
9 GRAPHIC tm254675d1_8kimg005.jpg GRAPHIC 33101
10 GRAPHIC tm254675d1_8kimg006.jpg GRAPHIC 74688
11 GRAPHIC tm254675d1_8kimg007.jpg GRAPHIC 20958
  Complete submission text file 0001104659-25-007198.txt   1036455

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA immu-20250129.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20250129_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20250129_pre.xml EX-101.PRE 22359
23 EXTRACTED XBRL INSTANCE DOCUMENT tm254675d1_8k_htm.xml XML 3688
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 25569316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)